Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kala Pharmaceuticals, Inc. (KALA)  
$6.90 0.19 (2.79%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 1,518,000
Market Cap: 10.47(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.2 - $18.63
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kala Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of therapies for diseases of the eye. Co.'s two marketed products are EYSUVIS® (loteprednol etabonate ophthalmic suspension) 0.25%, for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease, and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1%, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Co. is also progressing its pipeline of proprietary programs targeted to address front and back of the eye diseases, including KPI-287 and glucocorticoid receptor modulators.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 11,400 11,400 3,865,837
Total Sell Value $0 $76,777 $76,777 $1,938,481
Total People Sold 0 6 6 7
Total Sell Transactions 0 6 6 15
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 144
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bazemore Todd Chief Operating Officer   •       –      –    2020-03-16 4 B $5.75 $57,500 D/D 10,000 10,000 2.74 59%     
   Grunberg Gregory Director   –       •      –    2020-03-13 4 B $7.89 $19,999,998 I/I 2,534,854 2,534,854 2.1 58%     
   Shah Rajeev M. Director   –       •       •   2020-03-13 4 B $7.89 $49,999,995 I/I 6,337,135 10,874,613 2.25 58%     
   Kolchinsky Peter Director   –       •       •   2020-03-13 4 B $7.89 $49,999,995 I/I 6,337,135 10,874,613 2.25 58%     
   Rosen Howard B Director   –       •      –    2019-05-30 4 B $5.42 $27,100 D/D 5,000 8,240 2.39     -
   Grunberg Gregory Director   –       •      –    2018-10-05 4 B $8.25 $4,999,995 I/I 606,060 2,877,006 2.1     -
   Kolchinsky Peter Director   –       •       •   2018-10-03 4 B $8.25 $19,999,997 I/I 2,424,242 4,537,478 2.25     -
   Shah Rajeev M. Director   –       •       •   2018-10-03 4 B $8.25 $19,999,997 I/I 2,424,242 4,537,478 2.25     -
   Chen Hongming Chief Scientific Officer   •       –      –    2018-02-28 4 OE $2.24 $22,123 D/D 9,769 55,849     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-02-08 4 B $12.93 $323,250 I/I 25,000 3,447,840 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-02-02 4 B $14.73 $557,383 I/I 37,840 3,422,840 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-02-01 4 B $14.99 $342,372 I/I 22,840 3,385,000 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-31 4 B $15.00 $5,091,000 I/I 339,400 3,362,160 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-29 4 B $14.99 $749,500 I/I 50,000 3,022,760 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-26 4 B $14.93 $339,807 I/I 22,760 2,972,760 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-24 4 B $14.91 $963,738 I/I 64,637 2,950,000 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-23 4 B $14.99 $65,401 I/I 4,363 2,885,363 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-22 4 B $14.98 $1,123,500 I/I 75,000 2,881,000 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-19 4 B $14.95 $1,120,218 I/I 74,931 2,806,000 1.5     -
   Orbimed Capital Gp Vi Llc 10% Owner   –       –       •   2018-01-12 4 B $14.50 $556,133 I/I 38,354 2,731,069 1.5     -
   Isaly Samuel D 10% Owner   –       –       •   2018-01-12 4 B $15.40 $438,068 I/I 28,446 2,692,715 1.5     -
   Isaly Samuel D 10% Owner   –       –       •   2018-01-11 4 B $13.65 $569,205 I/I 41,700 2,664,269 1.5     -
   Isaly Samuel D 10% Owner   –       –       •   2018-01-10 4 B $12.83 $2,185,437 I/I 170,338 2,622,569 1.5     -
   Brazzell Kim Chief Medical Officer   •       –      –    2017-08-11 4 OE $0.68 $178,039 D/D 108,725 108,725     -
   Isaly Samuel D See Remarks   –       –       •   2017-07-25 4 B $15.00 $4,789,995 I/I 319,333 2,375,279 1.5     -
  144 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us